Norcolut with immune modulators in the complex treatment for hyperplastic uterine processes.
Zaporozhan. V N VN; Khait. O V OV; Tumasyan. K P KP
Key Findings
- Combination of norcolut, thymalinum, and myelopidum was tested in 55 patients with hyperplastic endometrium
- The added immune modulators appeared to increase overall treatment effectiveness
- The study does not provide detailed dosing or safety data for broader use
Practical Outcomes
- For most biohackers, this finding has little direct relevance because it targets a niche women's health issue and lacks clear protocols for general health or longevity. It may be of interest only to those specifically researching uterine health or immune modulation in similar contexts.
Summary
A small study on 55 women with thickened uterine lining showed that adding the immune‑modulating peptide thymalin (called thymalinum) to a drug called norcolut, along with another agent, seemed to improve treatment results, but the research is limited to a specific gynecological condition.
Abstract
The results are presented of the treatment of 55 patients for hyperplastic endometrial processes with the preparation norcolut combined with the immune modulators thymalinum and myelopidum. It was found that the application of the suggested schemes of the introduction of the medicines mentioned increase the treatment effectiveness and enlarges its possibilities.
Study Information
pubmed
1993